The Evolution of Combination Therapies in the Treatment of Melanoma

September 27, 2013 | Jeffrey Infante, MD

Join MIF and Dr. Jeffrey Infante as we discuss the evolution of combination therapies in the treatment of melanoma. Dr. Infante is the Director of Drug Development at the Sarah Cannon Research Institute /Tennessee Oncology.

infante Presented by Jeffrey Infante, MD